{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T17:20:21Z","timestamp":1759339221170},"reference-count":25,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archivos de Bronconeumolog\u00eda"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/j.arbres.2013.09.016","type":"journal-article","created":{"date-parts":[[2013,12,7]],"date-time":"2013-12-07T17:15:24Z","timestamp":1386436524000},"page":"93-98","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Oportunidades perdidas de vacunaci\u00f3n antineumoc\u00f3cica. \u00bfSe puede hacer algo m\u00e1s en prevenci\u00f3n?"],"prefix":"10.1016","volume":"50","author":[{"given":"Mercedes","family":"Arencibia Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Francisco","family":"Navarro Gracia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Antonio","family":"Delgado de los Reyes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerardo","family":"P\u00e9rez Torregrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"L\u00f3pez Parra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"L\u00f3pez Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arbres.2013.09.016_bib0005","series-title":"La enfermedad neumoc\u00f3cica y su prevenci\u00f3n. Caminando hacia el futuro","first-page":"113","article-title":"Epidemiolog\u00eda de la enfermedad neumoc\u00f3cica en el adulto","author":"Salleras","year":"2010"},{"key":"10.1016\/j.arbres.2013.09.016_bib0010","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.vaccine.2010.11.025","article-title":"The burden of hospitalisations for community- acquired pneumonia (CAP) and pneumococcal pneumonia in adults in Spain (2003-2007)","volume":"29","author":"Gil-Prieto","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.arbres.2013.09.016_bib0015","unstructured":"World Health Organization. 23-valent pneumococcal polysaccharide vaccine. [position paper]. Wkly Epidemiol Rec. 2008; 83: 373-84 [acceso 2 Sep 2013]. Disponible en: www.who.int\/wer\/2008\/wer8342.pdf"},{"key":"10.1016\/j.arbres.2013.09.016_bib0020","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jinf.2012.02.017","article-title":"The effect of underlying clinical conditions on the risk of developing invasive pneumococcal disease in England","volume":"65","author":"Van Hoek","year":"2012","journal-title":"J Infect"},{"key":"10.1016\/j.arbres.2013.09.016_bib0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ijantimicag.2012.03.001","article-title":"Variations in serotypes and susceptibility of adult non-invasive Streptococcus pneumoniae isolates between the periods before (May 2000-May 2001) and 10 years after (May 2010-May 2011) introduction of conjugate vaccines for child immunisation in Spain","volume":"40","author":"Fenoll","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.arbres.2013.09.016_bib0030","unstructured":"Direcci\u00f3n General para la Salut P\u00fablica, Conseller\u00eda de Sanitat. Bueno FJ, LLuch JA, Pastor E, Sanz M. Vacuna contra el Neumococo. \u00abGu\u00eda practica para profesionales sanitarios\u00bb. Monograf\u00eda sanitaria serie E. N.o 34. Generalitat Valenciana. [acceso 2 Sep 2013]. Disponible en: http:\/\/publicaciones.san.gva.es\/publicaciones\/documentos\/V.;1; 4058-2000.pdf"},{"key":"10.1016\/j.arbres.2013.09.016_bib0035","unstructured":"Servicio de Epidemiolog\u00eda y Vigilancia de la Salud. Direcci\u00f3n General de Salud P\u00fablica. Generalitat Valenciana. Enfermedad neumoc\u00f3cica invasora (ENI) Informes 2007 a 2011. [Internet]. Valencia: Generalitat Valenciana [acceso 2 Sep 2013]. Disponible en: http:\/\/www.sp.san.gva.es\/sscc\/opciones4.jsp?CodPunto=2903&Seccion=SANPCI1070205&ShowTitle=true&Opcion=SANMCI10702&MenuSup=SANMCI107&Nivel=2&perfil=ciud"},{"key":"10.1016\/j.arbres.2013.09.016_bib0040","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1157\/13106279","article-title":"Vacunaci\u00f3n antineumoc\u00f3cica en la poblaci\u00f3n mayor de 65 a\u00f1os","volume":"39","author":"Vila C\u00f3rcoles","year":"2007","journal-title":"Aten Primaria"},{"key":"10.1016\/j.arbres.2013.09.016_bib0045","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.vaccine.2003.09.027","article-title":"Precise answers to the wrong questions: Prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults","volume":"22","author":"Fedson","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.arbres.2013.09.016_bib0050","first-page":"CD000422","article-title":"Vaccines for preventing pneumococcal infection in adults","volume":"23","author":"Moberley","year":"2008","journal-title":"Cochrane Database syst Rev"},{"key":"10.1016\/j.arbres.2013.09.016_bib0055","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1001\/archinte.161.22.2702","article-title":"Generalist and subspecialist physicians knowledge, attitudes and practices regarding influenza and pneumococcal vaccinations for elderly and other high-risk patients: A nation-wide survey","volume":"161","author":"Nichol","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.arbres.2013.09.016_bib0060","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1503\/cmaj.080734","article-title":"Efficacy of pneumococcal vaccination in adults: A meta-analysis","volume":"180","author":"Huss","year":"2009","journal-title":"CMAJ"},{"issue":"RR\u201308","key":"10.1016\/j.arbres.2013.09.016_bib0065","first-page":"1","article-title":"Prevention of pneumococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"46","year":"1997","journal-title":"MMWR Recomm, Rep"},{"key":"10.1016\/j.arbres.2013.09.016_bib0070","first-page":"1102","article-title":"Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine, (PPSV23)","volume":"59","year":"2010","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.arbres.2013.09.016_bib0075","unstructured":"INE: Instituto Nacional de Estad\u00edstica [Internet]. Madrid: INE; 2012 (citado 6 Dic 2012). Censo oficial de poblaci\u00f3n [aprox. 3 pantallas]. Disponible en: http:\/\/www.ine.es\/inebmenu\/mnu_analisis.htm"},{"issue":"Supl 1","key":"10.1016\/j.arbres.2013.09.016_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0213-9111(11)70008-5","article-title":"Evaluaci\u00f3n de la efectividad de los programas de vacunaci\u00f3n","volume":"25","author":"Borras","year":"2011","journal-title":"Gac Sanit"},{"key":"10.1016\/j.arbres.2013.09.016_bib0085","series-title":"Vacunaciones preventivas: principios y aplicaciones","first-page":"781","article-title":"Evaluaci\u00f3n de la eficacia de las vacunas y de la efectividad de los programas de vacunaciones","author":"Salleras","year":"2003"},{"key":"10.1016\/j.arbres.2013.09.016_bib0090","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1017\/S0950268807008436","article-title":"Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999-2005","volume":"136","author":"Pebody","year":"2008","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.arbres.2013.09.016_bib0095","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.amepre.2010.06.004","article-title":"Pneumococcal polysaccharide vaccination among adults aged 65 years and older. U. S., 1989-2008","volume":"39","author":"Lu","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.arbres.2013.09.016_bib0100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/aje\/kwr376","article-title":"Uptake of pneumococcal polysaccharide vaccination among working-age adults with underlying medical conditions. United States, 2009","volume":"175","author":"Peng-Jum","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.arbres.2013.09.016_bib0105","first-page":"348","article-title":"Conocimiento y adherencia a las recomendaciones de vacunaci\u00f3n antineumoc\u00f3cica en adultos entre m\u00e9dicos de atenci\u00f3n primaria y hospitalaria [carta cient\u00edfica]","volume":"30","author":"Fernandez-Ruiz","year":"2012","journal-title":"Enferm Infecc Microgiol Clin"},{"key":"10.1016\/j.arbres.2013.09.016_bib0110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S1138-3593(05)72886-0","article-title":"Efectividad de la vacuna antineumoc\u00f3cica de 23 polisac\u00e1ridos","volume":"31","author":"De-Juanes Pardo","year":"2005","journal-title":"Semergen"},{"key":"10.1016\/j.arbres.2013.09.016_bib0115","first-page":"816","article-title":"Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.arbres.2013.09.016_bib0120","first-page":"394","article-title":"Licensure of 13-valent pneumococcal conjugate vaccine for adults aged 50 years, and older","volume":"61","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.arbres.2013.09.016_bib0125","unstructured":"Dominguez V, Arrazola P, Campins M, Chamorro J, de Diego J, Fenoll A, et al. Recomendaciones de vacunaci\u00f3n antineumoc\u00f3cica en el adulto por indicaci\u00f3n m\u00e9dica [acceso 2 Sep 2013] Disponible en: http:\/\/www.sempsph.com\/images\/stories\/recursos\/pdf\/protocolos\/2012\/Recom_Vac_Antineumococica_SEMPSPH.pdf"}],"container-title":["Archivos de Bronconeumolog\u00eda"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289613003116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0300289613003116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T05:27:54Z","timestamp":1538976474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0300289613003116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S0300289613003116"],"URL":"https:\/\/doi.org\/10.1016\/j.arbres.2013.09.016","relation":{},"ISSN":["0300-2896"],"issn-type":[{"value":"0300-2896","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oportunidades perdidas de vacunaci\u00f3n antineumoc\u00f3cica. \u00bfSe puede hacer algo m\u00e1s en prevenci\u00f3n?","name":"articletitle","label":"Article Title"},{"value":"Archivos de Bronconeumolog\u00eda","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arbres.2013.09.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 SEPAR. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}